These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11293921)

  • 1. Soluble L-selectin levels during controlled ovarian hyperstimulation.
    Orvieto R; Ben-Rafael Z; Schwartz A; Abir R; Fisch B; La-Marca A; Bar-Hava I
    Gynecol Endocrinol; 2001 Feb; 15(1):29-33. PubMed ID: 11293921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
    Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
    Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of urinary versus recombinant gonadotropin on serum P-selectin levels in vivo.
    Orvieto R; La Marca A; Badir W; Golan O; Bar J; Fisch B
    Gynecol Endocrinol; 2005 Apr; 20(4):185-7. PubMed ID: 16019359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation.
    Orvieto R; Zagatsky I; Yulzari-Roll V; La Marca A; Fisch B
    Gynecol Endocrinol; 2006 Aug; 22(8):437-40. PubMed ID: 17012105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD40 ligand levels during controlled ovarian hyperstimulation--a possible culprit of systemic inflammation.
    Orvieto R; Schachter B; Yulzari-Roll V; La Marca A; Bar J; Fisch B
    Am J Reprod Immunol; 2006 Oct; 56(4):243-8. PubMed ID: 16938113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian androgens but not estrogens correlate with the degree of systemic inflammation observed during controlled ovarian hyperstimulation.
    Orvieto R; Fisch N; Yulzari-Roll V; La Marca A
    Gynecol Endocrinol; 2005 Sep; 21(3):170-3. PubMed ID: 16335910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled ovarian hyperstimulation--a state of endothelial activation.
    Orvieto R; Schwartz A; Bar-Hava I; Abir R; Ashkenazi J; La-Marca A; Ben-Rafael Z
    Am J Reprod Immunol; 2000 Nov; 44(5):257-60. PubMed ID: 11125785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol.
    Orvieto R; Volodarsky M; Hod E; Homburg R; Rabinson J; Zohav E; Anteby EY; Meltcer S
    Gynecol Endocrinol; 2007; 23(8):494-6. PubMed ID: 17852411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled ovarian hyperstimulation: a state of neutrophil activation.
    Orvieto R; Ben-Rafael Z; Abir R; Bar-Hava I; Fisch B; Molad Y
    Am J Reprod Immunol; 1999 Nov; 42(5):288-91. PubMed ID: 10584983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum P-selectin level during controlled ovarian hyperstimulation--a preliminary report.
    Orvieto R; Badir W; Bar J; La Marca A; Ashkenazi J; Avrech OM; Fisch B
    Am J Reprod Immunol; 2004 Aug; 52(2):139-42. PubMed ID: 15274655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle.
    Orvieto R; Chen R; Ashkenazi J; Ben-Haroush A; Bar J; Fisch B
    Hum Reprod; 2004 Feb; 19(2):357-9. PubMed ID: 14747180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and follicular fluid leptin levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycle.
    Chen R; Fisch B; Ben-Haroush A; Kaplan B; Hod M; Orvieto R
    Clin Exp Obstet Gynecol; 2004; 31(2):103-6. PubMed ID: 15266760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
    Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization].
    Ye H; Huang G; Pei L
    Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):222-5. PubMed ID: 11783366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 production in whole blood cell cultures of women undergoing controlled ovarian hyperstimulation for assisted reproduction technology cycles.
    Orvieto R; Leites T; Abir R; Bar J; Yoeli R; Feldberg D; Fisch B
    Am J Reprod Immunol; 2003 Sep; 50(3):220-3. PubMed ID: 14629026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation of serum and follicular fluid leptin and ovarian steroid levels in response to induction of ovulation in in vitro fertilization cycles.
    Gürbüz B; Yalti S; Ficicioglu C; Taşdemir S
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):214-8. PubMed ID: 15653206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum progesterone at human chorionic gonadotropin injection significantly correlate with female age.
    Doldi N; Persico P; De Santis L; Rabellotti E; Papaleo E; Ferrari A
    Minerva Ginecol; 2005 Aug; 57(4):477-82. PubMed ID: 16170294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.